DEGS1-mTORC1-driven lipid metabolic reprogramming fuels rhabdomyosarcoma progression and unveils a therapeutic vulnerability
Rhabdomyosarcoma is an aggressive childhood cancer with limited treatment options for advanced disease.
Rhabdomyosarcoma is an aggressive childhood cancer with limited treatment options for advanced disease.